Clinical Characteristics and Risk Factors for Symptomatic Pediatric Gallbladder Disease

Page created by Jimmie Flores
 
CONTINUE READING
ARTICLE

Clinical Characteristics and Risk Factors for
Symptomatic Pediatric Gallbladder Disease
AUTHORS: Seema Mehta, MD,a Monica E. Lopez, MD,b                           WHAT’S KNOWN ON THIS SUBJECT: Gallbladder disease in
Bruno P. Chumpitazi, MD,a Mark V. Mazziotti, MD,b                          children is an evolving entity and studies suggest an increasing
Mary L. Brandt, MD,b and Douglas S. Fishman, MDa                           frequency of symptomatic pediatric gallbladder disease and
aDepartment of Pediatrics, Baylor College of Medicine, Section of          resultant cholecystectomies.
Gastroenterology, Hepatology, and Nutrition, Texas Children’s
Hospital, Houston, Texas; bMichael E. DeBakey Department of                WHAT THIS STUDY ADDS: Hispanic ethnicity and obesity are
Surgery, Baylor College of Medicine; Division of Pediatric Surgery,
Texas Children’s Hospital, Houston, Texas
                                                                           epidemiologically significant risk factors for symptomatic
                                                                           gallbladder disease in the pediatric population.
KEY WORDS
children, cholecystectomy, gallbladder, Hispanic, obesity
ABBREVIATIONS
ERCP—endoscopic retrograde cholangiopancreatography
HIDA—hepatobiliary iminodiacetic acid
IOC—intraoperative cholangiogram
TCH—Texas Children’s Hospital
                                                                      abstract
                                                                      OBJECTIVE: Our center previously reported its experience with pedi-
All authors contributed extensively to this study. Drs Mehta,
Lopez, Brandt, and Fishman conceived and designed the study.          atric gallbladder disease and cholecystectomies from 1980 to 1996. We
Drs Mehta, Lopez, and Fishman acquired the data. Drs Mehta,           aimed to determine the current clinical characteristics and risk fac-
Chumpitazi, and Fishman analyzed and interpreted the data. Drs        tors for symptomatic pediatric gallbladder disease and cholecystecto-
Mehta, Brandt, and Fishman drafted the manuscript. All authors
contributed to critical revisions of the manuscript and gave final     mies and compare these findings with our historical series.
approval of the version to be published.                              STUDY DESIGN: Retrospective, cross-sectional study of children, 0 to 18
www.pediatrics.org/cgi/doi/10.1542/peds.2011-0579                     years of age, who underwent a cholecystectomy from January 2005 to
doi:10.1542/peds.2011-0579                                            October 2008.
Accepted for publication Sep 9, 2011                                  RESULTS: We evaluated 404 patients: 73% girls; 39% Hispanic and 35%
Address correspondence to Seema Mehta, MD, 6621 Fannin                white. The mean age was 13.10 6 0.91 years. The primary indications
Street, CC1010.02, Houston, TX 77030. E-mail: seemam@bcm.edu
                                                                      for surgery in patients 3 years or older were symptomatic cholelithi-
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).       asis (53%), obstructive disease (28%), and biliary dyskinesia (16%).
Copyright © 2012 by the American Academy of Pediatrics                The median BMI percentile was 89%; 39% were classified as obese. Of
FINANCIAL DISCLOSURE: The authors have indicated they have            the patients with nonhemolytic gallstone disease, 35% were obese and
no financial relationships relevant to this article to disclose.
                                                                      18% were severely obese; BMI percentile was 99% or higher. Gallstone
                                                                      disease was associated with hemolytic disease in 23% (73/324) of patients
                                                                      and with obesity in 39% (126/324). Logistic regression demonstrated older
                                                                      age (P = .019) and Hispanic ethnicity (P , .0001) as independent risk
                                                                      factors for nonhemolytic gallstone disease. Compared with our historical
                                                                      series, children undergoing cholecystectomy are more likely to be
                                                                      Hispanic (P = .003) and severely obese (P , .0279).
                                                                      CONCLUSION: Obesity and Hispanic ethnicity are strongly correlated
                                                                      with symptomatic pediatric gallbladder disease. In comparison with
                                                                      our historical series, hemolytic disease is no longer the predominant
                                                                      risk factor for symptomatic gallstone disease in children. Pediatrics
                                                                      2012;129:1–7

PEDIATRICS Volume 129, Number 1, January 2012                                                                                                 1
                                                  Downloaded from by guest on November 4, 2015
Gallbladder disease in children is            We hypothesize that the epidemiologic       Nutrition and Research Center com-
evolving and studies suggest an ever-         risk factors for pediatric gallbladder      puterized calculator, which is based
increasing frequency of gallbladder           disease now resemble those seen in          on the Centers for Disease Control
disease and resultant cholecystecto-          adults (eg, female gender, race, and        and Prevention’s standardized charts
mies in children.1–8 In 1959, the pre-        obesity).19,25–28 In this retrospective     (http://www.bcm.edu/cnrc/bodycomp/
valence of cholelithiasis in children         series of consecutive children under-       bmiz2.html). BMI percentiles were cat-
younger than 16 years was noted to be         going cholecystectomy, we aimed to          egorized as follows: lower than 85%,
0.15%.9 Since that time, the prevalence       identify the clinical characteristics and   normal weight; 85% to 94.9%, over-
has increased with estimates ranging          risk factors for pediatric gallbladder      weight; 95% to 98.9%, obese; and 99%
from 1.9% to 4.0%.3–6 The number of           disease resulting in cholecystectomy        or higher, severely obese.
cholecystectomies has increased ac-           and to compare current demographics         SPSS 17.0 (Chicago, IL) was used for all
cordingly. At our own institution, 36 cho-    and indications for surgery with our        statistical analyses. Comparison of
lecystectomies were performed from            historical series.1                         categorical values between groups was
1960 to 1980, and 128 were performed                                                      done via x 2 analyses. Comparison of
over the next 17 years (1980–1997).1,10       METHODS                                     continuous variables between groups
Cholelithiasis in infancy is typically re-    The Texas Children’s Hospital (TCH) pa-     was completed with Mann-Whitney
lated to prematurity, total parenteral        thology database was used to identify       U analysis. Binary multivariate logistic
nutrition use, abdominal surgery, or          all patients, 0 to 18 years of age, who     regression analysis with presence or
sepsis.2,11–13 During adolescence, pre-       underwent a cholecystectomy from            absence of gallstone disease as the
vious reports identified hemolytic dis-        January 2005 through October 2008. All      dependent variable was completed. A
ease as the most common associated            patients who underwent an incidental        P value # .05 was used to indicate
comorbidity. More recent data sug-            cholecystectomy secondary to liver          statistical significance. Z-scores were
gest that gallbladder disease related         transplantation or hepatobiliary sur-       used for all statistical analyses of BMI.
to nonhemolytic risk factors, including       gery (eg, Kasai portoenterostomy) were      BMI was not calculated for patients
pregnancy, oral contraceptive use, and        excluded.                                   younger than 3 years because only a
obesity, is on the rise.1,2,14–16                                                         length was available for these patients,
                                              The medical records of study patients
                                                                                          not a height; therefore, these patients
The change in etiology of gallbladder         were examined for demographics (age,
                                                                                          were excluded from BMI analyses.29
disease is temporally related to the          gender, race/ethnicity), anthropomor-
well-documented rise in childhood             phic measurements (weight, height),         Hemolytic disease is a well-described,
obesity. The NHANES data from 2003 to         comorbidities, primary and secondary        strong independent risk factor for
2004 revealed the prevalence of child-        indications for cholecystectomy, find-       cholelithiasis; therefore, patients with
hood obesity in the United States to be       ings on imaging studies (hepatobiliary      hemolytic disease (sickle cell anemia,
17.1%, compared with 13.9% from 1999          iminodiacetic acid [HIDA] scan, abdo-       hereditary spherocytosis, hemoglobin
to 2000.17 In addition, the prevalence of     minal ultrasound, magnetic resonance        H disease, autoimmune hemolytic ane-
severe obesity, BMI percentile of 99%         cholangiopancreatography) and/or            mia, congenital dyserythropoietic ane-
or higher, increased by more than             endoscopic retrograde cholangio-            mia) were excluded when assessing the
300%: 0.8% from 1976 to 2000 to 3.8%          pancreatography (ERCP), and histo-          impact of other potential risk factors,
from 1999 to 2004.18 Severe obesity was       pathology. Patients were identified as       age, gender, BMI, and race, on gallstone
noted to be the highest among African         having a primary indication of compli-      formation.30–33
American and Hispanic individuals.18          cated obstructive disease if they were
                                                                                          RESULTS
The relationship between obesity and          diagnosed with gallstone pancreatitis,
gallbladder disease is well recognized in     jaundice, choledocholithiasis, or found     Patient Population
the adult population.19,20 Obesity has        to have dilation of the common bile duct    A total of 455 cholecystectomies were
previously been described as a rare risk      on an imaging study. This study was         completed at TCH from January 2005 to
factor for gallbladder disease in chil-       conducted after approval from the           October 2008. Of these, 404 patients met
dren; however, as a result of the obesity     Baylor College of Medicine Institutional    inclusion criteria (Fig 1). Demographic
epidemic, obesity-related comorbidities,      Review Board.                               data for these patients are shown in
including gallbladder disease, are in-        BMI (kg/m2), Z-scores, and BMI per-         Table 1. The BMI distribution of all
creasingly affecting the pediatric pop-       centiles were calculated using the          patients $3 years of age was as follows:
ulation.1,2,13,14,21–24                       Baylor College of Medicine Children’s       45% (n = 174) were considered to be

2    MEHTA et al
                                             Downloaded from by guest on November 4, 2015
ARTICLE

                                                                                                  TABLE 2 Primary Comorbidities
                                                                                                  Hemolytic disease                76 (19%)
                                                                                                  Obesity                          18 (4%)
                                                                                                  Post partum                      14 (3%)
                                                                                                  Malignancy                        9 (2%)
                                                                                                  Polycystic ovary syndrome         6 (2%)
                                                                                                  Thyroid disease                   5 (2%)
                                                                                                  Cardiac disease                   7 (1.5%)
                                                                                                  Diabetes                          5 (1%)
                                                                                                  Prematurity                       4 (1%)
                                                                                                  Hyperlipidemia                    4 (1%)
                                                                                                  Cystic fibrosis                    2 (0.5%)
FIGURE 1                                                                                          Gilbert disease                   1 (0.2%)
Excluded patients.                                                                                Others                           38 (9%)
                                                                                                  None                            216
TABLE 1 Demographics                                 (n = 2). A primary indication was not
Age, y                                               identified for one patient. For those         3 to 7 years old, and 3% (n = 7) were
  Range                                0.6–18.0      patients younger than 3 years, symp-         younger than 3 years. Most of the
  Mean                                    13
  Median                                  14
                                                     tomatic cholelithiasis (n = 5, 71%) and      patients (76%, n = 190) were girls.
  Age categories, n (%)                              complicated obstructive disease (n = 2,      For patients $3 years old with non-
     13–18 y                           271 (67)      29%) were the primary indications for        hemolytic gallstone disease (n = 244),
     8–12 y                             88 (22)
                                                     surgery. Gallstones were identified on        the BMI percentile distribution was as
     3–7 y                              38 (9)
     Younger than 3 y                    7 (2)       gross pathology or imaging in 80%            follows: 31% (n = 74) were considered
Gender                                               (324/404) of patients. None of the pa-       to be a normal weight, 16% (n = 37)
  Males, n (%)                         111 (27)      tients with biliary dyskinesia (n = 64)
  Females, n (%)                       293 (73)                                                   were overweight, 35% (n = 82) were
  Male:Female                           1.0:2.6      or gallbladder polyps (n = 3) had evi-       obese, and 18% (n = 44) were severely
Race/Ethnicity, n (%)                                dence of gallstones.                         obese. As such, ∼69% (n = 163/237) of
  Hispanic                             144 (39)
  White                                126 (35)
                                                     Patients with complicated obstructive        patients with gallstone disease were
  African American                      90 (25)      disease (n = 112) presented with one or      overweight or obese. The median BMI
  Other                                  5 (1)       a combination of the following: chol-        percentile for these patients was 95%
  Unknown                               39 (10)
                                                     edocholithiasis (n = 43), gallstone pan-     and the mean BMI percentile was 81%. A
                                                     creatitis (n = 42), jaundice (n = 16), and   height or weight was absent for 7 pa-
a normal weight, 16% (n = 63) were                   dilation of the common bile duct (n = 64).   tients with gallstone disease; therefore,
overweight, 24% (n = 94) were obese,                 More than one-third of patients with         these patients were excluded from all
and 15% (n = 57) were severely obese.                complicated obstructive disease (n = 42;     BMI analyses.
The median BMI percentile was 89%.                   38%) presented with a combination of         Logistic regression was used to predict
Of the patients with a BMI percentile                obstructive findings.                         the impact of gender, age, BMI, and
$95%, 52% (n = 79) were Hispanic. A                  Associated comorbidities were identi-        Hispanic ethnicity on the incidence of
height or weight was unavailable for                 fied for 189 (47%) of 404 patients. These     nonhemolytic gallstone disease. Older
9 patients; therefore, these patients                are listed in Table 2. A positive family     age (P = .019) and Hispanic ethnicity
were excluded from all BMI analyses.                 history of cholelithiasis was reported       (P , .0001) were independent risk
                                                     for only 9 patients.                         factors for nonhemolytic gallstone dis-
Indications                                                                                       ease. Gender and BMI percentile were
The primary indications for cholecys-                Gallstone Disease: Risk Factors              not independent risk factors.
tectomy in patients $3 years of age                  Of the 76 children with hemolytic dis-
were symptomatic cholelithiasis (n =                 ease, 73 (96%) were diagnosed with           Complicated Obstructive Disease
211; 53%), complicated obstructive                   gallstone disease. Nonhemolytic gall-        Complicated obstructive disease was
disease (n = 112; 28%), and biliary                  stone disease occurred in 77% (251/          the primary indication for a cholecys-
dyskinesia (n = 64; 16%). Other indi-                324) of patients. The age distribution       tectomy in 112 patients $3 years of age.
cations included acalculous cholecys-                of patients with nonhemolytic gallstone      Of these, 61 had a BMI percentile $85%
titis (n = 4), gallbladder polyps (n = 3),           disease was as follows: 76% (n = 192)        (P = .496). Univariate analysis identified
and persistent right upper quadrant                  were 13 to 18 years old, 16% (n = 39)        a significant association between the
abdominal pain of unknown etiology                   were 8 to 12 years old, 5% (n = 13) were     risk for gallstone pancreatitis and a BMI

PEDIATRICS Volume 129, Number 1, January 2012                                                                                             3
                                                Downloaded from by guest on November 4, 2015
percentile $85% (P = .003); however,          children with hemolytic disease. The                 complications were postoperative fever
this association was not found for            overall percentage of patients with                  and pancreatitis/pseudocyst formation
jaundice (P = not significant). Hispanic       hemolytic disease as an indication for               (Table 4). Of the obese patients, 15% (n =
patients (n = 55, 65%) were more likely       cholecystectomy has decreased sig-                   23) had a minor or major postoperative
than non-Hispanic patients (n = 29,           nificantly (41% vs 18%, P , .0001).                   complication (P = .4). No deaths oc-
35%) to have obstructive disease (P =         Additionally, no cholecystectomies were              curred as a result of a cholecystectomy
.005). Of the 112 patients with compli-       previously performed for biliary dyski-              in our current series. In our previous
cated obstructive disease, 56% (n = 63)       nesia, whereas now it is the third lead-             series, 3 children with congenital heart
underwent the following additional            ing indication (0% vs 16%, P , .0001).               disease who required emergent chole-
procedures: ERCP (n = 21), intraop-           Another significant change has been in                cystectomy died after surgery.1
erative cholangiogram (IOC) (n = 28),         the approach to surgery. In our current
or ERCP and IOC (n = 14).                     series, 97% of cholecystectomies were                DISCUSSION
                                              performed laparoscopically versus 15%                We have found that cholecystectomies
Biliary Dyskinesia                            in our previous series. The major com-               for gallbladder disease are performed
Biliary dyskinesia, by definition, is a        plication rate remains similar (9% vs                more often in children and the risk
gallbladder ejection fraction of ,35%         9%) (Table 3). The most common major                 factors for cholecystectomies have
with a cholecystokinin analog infusion
on HIDA scan.34–37 Biliary dyskinesia was
                                              TABLE 3 Texas Children’s Hospital Historical Comparison1
the third leading indication for a cho-
                                                                                       1980–1996             2005–2008                      P Value
lecystectomy in our patient cohort.
                                              Total no. of patients                    128                    404
Females comprised 78% of these                Age, y
patients, and 18% were of Hispanic eth-          Mean                                   10                  13.00 6 0.19
nicity. Fifty-one percent of patients were    Gender
                                                 Males                                  59 (46%)              111 (27%)                        .0001
overweight and, of these, 30% were
                                                 Females                                69 (54%)              293 (73%)                        .0001
severely obese. HIDA scans completed             Male:Female                             0.8:1                  1:2.6
on all 64 patients revealed an ejection       Race/Ethnicity
fraction of less than 35% (median of             Hispanic                               28 (22%)              144 (36%)                        .003
                                                 White                                  57 (45%)              126 (31%)                        NS
10%; range 0%–34%). Histologic fea-              African American                       39 (30%)               90 (22%)                        NS
tures of chronic cholecystitis were              Other                                   4 (3%)                 5 (1%)                         NS
identified in 80% (n = 51) of patients         BMI
                                              Severely obese                             8 (6%)                57 (15%)                        .013
with a preoperative diagnosis of biliary      Comorbidities
dyskinesia.                                      Hemolytic disease                      52 (41%)               76 (19%)                     ,.0001
                                                 Biliary dyskinesia                      0                     64 (16%)                     ,.0001
                                              Surgery
Comparison With Historical Control               Laparoscopic                           19 (15%)              379 (96%)                     ,.0001
Miltenburg et al published data on pe-           Open                                  109 (85%)               17 (4%)                      ,.0001
                                              Major complication                        11 (9%)                38 (9%)                       NS
diatric cholecystectomies at TCH from
                                              NS, not significant.
1980 to 1996.1 We compared our data
with this historical cohort (Table 3).
There has been a notable increase in          TABLE 4 Postoperative Complications From the 2005–2008 Texas Children’s Hospital Cohort
the percentage of Hispanic (22% vs
                                                                    Major (n)                                                  Minor (n)
36%, P = .003) and severely obese (6%
                                              Postoperative fever (8)                                               Abdominal pain (13)
vs 18%, P , .027) patients undergoing         Pancreatitis/pseudocyst formation (7)                                 Nausea/Vomiting (nonbilious) (6)
cholecystectomy. Patients in the his-         Infection (eg, fungemia, urinary tract infection,                     Ileus (2)
torical cohort were subjectively cate-           wound infection) (5)
                                              Papillary stenosis/stricture (4)
gorized as being morbidly obese. BMI          Retained stone (4)
data for this historical cohort of            Jaundice (4)
patients was not available for direct         Bile leak (2)
comparison.                                   Vascular injury (1)
                                              Hemobilia (1)
In our historical series, 52 (41%) of 128     Small bowel obstruction (1)
cholecystectomies were performed on           Prolonged intubation (1)

4    MEHTA et al
                                             Downloaded from by guest on November 4, 2015
ARTICLE

changed. In the initial series from TCH,             dyskinesia, 78% were female and 70%          not previously been investigated. De-
36 cholecystectomies were performed                  were $13 years of age. These findings         spite 25% of the Hispanic children
in 20 years (1.8 per year), followed by              may support the suggestion that the          being overweight or obese, we dem-
128 in next 17 years (7.5 per year), and             hormonal changes occurring during            onstrate that independent of their BMI
now 404 in almost 4 years (101 per                   puberty may contribute to the impair-        percentiles, Hispanic children are at
year).1,10 Previously described risk                 ment of gallbladder motility in biliary      a greater risk for cholecystectomy be-
factors such as prematurity (n = 4, 1%)              dyskinesia by altering the lipid com-        cause of gallstone disease. This finding
and hemolytic disease (n = 76, 19%) did              position of bile, increasing cholesterol     supports the possible genetic risk
not account for this dramatic increase.              saturation, and promoting gallbladder        predisposition for stone formation in
Rather, risk factors responsible for the             hypomotility.43,45,46                        Hispanic children similar to that seen
development of gallbladder disease in                We also demonstrate a strong inde-           in Hispanic adults.52 Interestingly, we
adults (female gender, age, obesity,                 pendent correlation between BMI per-         identified only 9 patients, of whom only
and ethnicity) were identified as key                 centile and the presence of gallstone        5 were Hispanic, with a positive family
contributors to this increase in pedi-               disease. Based on their BMI, a remark-       history of cholelithiasis. We anticipate
atric gallbladder disease resulting in               able 69% of our patients with non-           that a positive family history may have
cholecystectomy.                                     hemolytic gallstone disease were             been underreported or family mem-
Our study mirrors previous observa-                  overweight or obese; however, only 6%        bers may have asymptomatic choleli-
tions that female children are at higher             of our patients had “obesity” docu-          thiasis. As such, race/ethnicity may be
risk of gallbladder disease than male                mented with an International Classifi-        a greater risk factor for gallstone dis-
children.1,2,7 A greater proportion of               cation of Diseases, Ninth Revision           ease than obesity alone. Further stud-
patients in our series were female                   code as a comorbidity in their medical       ies examining the independent risk of
(73%, n = 293), reflecting the trend to-              record, demonstrating a significant           race/ethnicity on the development of
ward gender bias. In adults, the high                underreporting of this condition. Obe-       gallstone disease are needed.
prevalence of cholelithiasis in women                sity is a major health care issue and its    To our knowledge, this is the largest
has been attributed to pregnancy and                 contribution to the prevalence of cho-       single-center study examining gall-
oral contraceptive use.38–43 We identi-              lelithiasis has been well elucidated         bladder disease in children who un-
fied 14 women with a documented                       in the adult population.19,20,27,28 The      derwent a cholecystectomy. Bogue et al8
pregnancy; however, our study design                 pathogenesis of gallstone formation in       recently studied 382 patients diag-
precluded the evaluation of patients                 obese individuals has been described         nosed with cholelithiasis based on
taking oral contraceptives.                          as multifactorial with key factors, in-      ultrasonography. In this series, only
We found an increase in the mean age of              cluding hepatic hypersecretion of            122 patients underwent a cholecystec-
diagnosis for gallstone disease. The                 cholesterol with resultant supersatu-        tomy. The racial and ethnic distribution
previous mean age for children with                  ration of bile and altered gallbladder       of their study population and its impact
gallstone disease has ranged from 8.4                motility.20,27,47 Our study strongly sug-    on the development of cholelithiasis
to 10.0 years; however, our mean age                 gests the obesity epidemic in children       was not described. Obesity was iden-
was notably higher at 13.0 years1,2                  has contributed significantly to the          tified in a significantly lower percent-
(67% were 13 to 18 years of age). This               striking increase in pediatric gallstone     age of patients than our study population,
phenomenon has previously been                       disease.                                     ,1% vs 53%. In addition, we report a
suggested and attributed to biliary                  Our data suggest that Hispanic ethnic-       higher rate of complicated disease in
cholesterol saturation occurring sec-                ity is also a significant risk factor for     patients requiring surgery, 10% vs 28%;
ondary to hormonal changes during                    pediatric gallbladder disease resulting      however, the definitions for compli-
puberty.43,44 An increase in the mean                in cholecystectomy. It has previously        cated disease varied between studies.
age at diagnosis may also be attribut-               been shown that Hispanic adults are at       Our definition did not include acute
able to the rising incidence of obesity in           increased risk for cholelithiasis.48–51      cholecystitis, whereas Bogue et al8 did
adolescents.                                         Genetic and environmental influences          not include jaundice or dilation of the
The hormonal changes associated with                 have been explored as potential ex-          common bile duct.
puberty may also play a role in the                  planations for this epidemiologic as-        Our study’s major strengths are a large
etiology of biliary dyskinesia. Of the               sociation.48,49,52,53 The impact of racial   sample size and diverse patient pop-
patients who underwent a cholecystec-                and ethnic variations on gallbladder         ulation. The study is limited by its ret-
tomy for the primary indication of biliary           disease in the pediatric population has      rospective design. At the time of our

PEDIATRICS Volume 129, Number 1, January 2012                                                                                             5
                                                Downloaded from by guest on November 4, 2015
final analysis, some data, including                       historical cohort and current patient                 cholecystectomies to laparoscopic
a height or weight for 9 of 404 patients,                 population may have been influenced                    cholecystectomies.
a race or ethnicity for 39 of 404, and an                 by the changing demographics of
indication for cholecystectomy for 1                      Houston and advances in medical care.                 CONCLUSION
patient, were missing. We believe that                    The Hispanic population of Houston,                   Hispanic ethnicity and obesity are
given our large sample size, the miss-                    Texas, has been steadily increasing                   epidemiologically significant risk fac-
ing data would not have significantly                      since 1980.54 This demographic change                 tors for gallbladder disease in the
altered our results. Additionally, BMI                                                                          pediatric population. Ethnicity is an
                                                          likely contributed to the increase in
data for our historical cohort was not                                                                          unalterable risk factor, but increased
                                                          the proportion of Hispanic children
available for direct comparison. With                                                                           awareness and early screening by
our stringent search criteria, all patients               undergoing cholecystectomies. We also
                                                                                                                pediatric health care providers could
who underwent a cholecystectomy                           surmise that biliary dyskinesia was
                                                                                                                potentially limit the occurrence of
during our study period should be                         identified as the third leading indication
                                                                                                                complicated obstructive disease. Ob-
represented; however, patients with                       for cholecystectomy in our cohort sec-                esity is a modifiable risk factor. With
gallbladder disease who did not have                      ondary to the rising awareness of the                 the prevalence of childhood obesity on
a cholecystectomy were not included in                    disease in the pediatric population.55,56             the rise, pediatric health care pro-
our epidemiologic data.30                                 In addition, the significant difference in             viders need to be more aware of
We recognize that some of the notable                     surgical practice is likely a reflection of            obesity-related comorbidities, includ-
differences identified between our                         the shift in standard of care from open               ing gallbladder disease.

REFERENCES
    1. Miltenburg DM, Schaffer R, III, Breslin T,          9. Glenn F. 25-years experience in the surgical            bile acids in paediatric gallstones. Dig Liver
       Brandt ML. Changing indications for pedi-              treatment of 5037 patients with non-                    Dis. 2010;42(1):61–66
       atric cholecystectomy. Pediatrics. 2000;105            malignant biliary tract disease. Surg Gynecol     17.   Ogden CL, Carroll MD, Curtin LR, McDowell
       (6):1250–1253                                          Obstet. 1959;109:591–606                                MA, Tabak CJ, Flegal KM. Prevalence of
    2. Friesen CA, Roberts CC. Cholelithiasis.            10. Pokorny WJ, Saleem M, O’Gorman RB,                      overweight and obesity in the United States,
       Clinical characteristics in children. Case             McGill CW, Harberg FJ. Cholelithiasis and               1999-2004. JAMA. 2006;295(13):1549–1555
       analysis and literature review. Clin Pediatr           cholecystitis in childhood. Am J Surg. 1984;      18.   Skelton JA, Cook SR, Auinger P, Klein JD,
       (Phila). 1989;28(7):294–298                            148(6):742–744                                          Barlow SE. Prevalence and trends of severe
    3. Shafer AD, Ashley JV, Goodwin CD, Nangas           11. Roslyn JJ, Berquist WE, Pitt HA, et al. In-             obesity among US children and adoles-
       VN Jr, Elliott D. A new look at the multi-             creased risk of gallstones in children re-              cents. Acad Pediatr. 2009;9(5):322–329
       factorial etiology of gallbladder disease in           ceiving total parenteral nutrition. Pediatrics.   19.   Shaffer EA. Epidemiology and risk factors
       children. Am Surg. 1983;49(6):314–319                  1983;71(5):784–789                                      for gallstone disease: has the paradigm
    4. Wesdorp I, Bosman D, de Graaff A, Aronson          12. King DR, Ginn-Pease ME, Lloyd TV, Hoffman               changed in the 21st century? Curr Gastro-
       D, van der Blij F, Taminiau J. Clinical pre-           J, Hohenbrink K. Parenteral nutrition with              enterol Rep. 2005;7(2):132–140
       sentations and predisposing factors of cho-            associated cholelithiasis: another iatrogenic     20.   Bennion LJ, Grundy SM. Effects of obesity
       lelithiasis and sludge in children. J Pediatr          disease of infants and children. J Pediatr              and caloric intake on biliary lipid metabolism
       Gastroenterol Nutr. 2000;31(4):411–417                 Surg. 1987;22(7):593–596                                in man. J Clin Invest. 1975;56(4):996–1011
    5. Lobe TE. Cholelithiasis and cholecystitis in       13. Debray D, Pariente D, Gauthier F, Myara A,        21.   Freedman DS, Dietz WH, Srinivasan SR,
       children. Semin Pediatr Surg. 2000;9(4):               Bernard O. Cholelithiasis in infancy: a                 Berenson GS. The relation of overweight to
       170–176                                                 study of 40 cases. J Pediatr. 1993;122(3):             cardiovascular risk factors among children
    6. Calabrese C, Pearlman DM. Gallbladder                  385–391                                                 and adolescents: the Bogalusa Heart Study.
       disease below the age of 21 years. Surgery.        14. Holcomb GW, Jr,O’Neill JA, Jr,Holcomb GW III.           Pediatrics. 1999;103(6 Pt 1):1175–1182
       1971;70(3):413–415                                     Cholecystitis, cholelithiasis and common          22.   American Diabetes Association. Type 2 di-
    7. Herzog D, Bouchard G. High rate of com-                duct stenosis in children and adolescents.              abetes in children and adolescents. Pedi-
       plicated idiopathic gallstone disease in               Ann Surg. 1980;191(5):626–635                           atrics. 2000;105(3 Pt 1):671–680
       pediatric patients of a North American ter-        15. Kaechele V, Wabitsch M, Thiere D, et al.          23.   Mallory GB, Jr,Fiser DH, Jackson R. Sleep-
       tiary care center. World J Gastroenterol. 2008;        Prevalence of gallbladder stone disease in              associated breathing disorders in morbidly
       14(10):1544–1548                                       obese children and adolescents: influence                obese children and adolescents. J Pediatr.
    8. Bogue CO, Murphy AJ, Gerstle JT, Moineddin             of the degree of obesity, sex, and pubertal             1989;115(6):892–897
       R, Daneman A. Risk factors, complications,             development. J Pediatr Gastroenterol Nutr.        24.   Quiros-Tejeira RE, Rivera CA, Ziba TT, et al.
       and outcomes of gallstones in children:                2006;42(1):66–70                                        Risk for nonalcoholic fatty liver disease in
       a single-center review. J Pediatr Gastro-          16. Koivusalo AI, Pakarinen MP, Sittiwet C, et al.          Hispanic youth with BMI $95th percentile.
       enterol Nutr. 2010;50(3):303–308                       Cholesterol, non-cholesterol sterols and                Hepatology. 2006;44(2):228–236

6       MEHTA et al
                                                         Downloaded from by guest on November 4, 2015
ARTICLE

25. Attili AF, Capocaccia R, Carulli N, et al;       36. Al-Homaidhi HS, Sukerek H, Klein M, Tolia V.      47. Marschall H-U, Einarsson C. Gallstone dis-
    Multicenter Italian Study on Epidemiology            Biliary dyskinesia in children. Pediatr Surg          ease. J Intern Med. 2007;261(6):529–542
    of Cholelithiasis. Factors associated with           Int. 2002;18(5-6):357–360                         48. Maurer KR, Everhart JE, Ezzati TM, et al.
    gallstone disease in the MICOL experience.       37. Hansel SL, DiBaise JK. Functional gallblad-           Prevalence of gallstone disease in Hispanic
    Hepatology. 1997;26(4):809–818                       der disorder: gallbladder dyskinesia. Gas-            populations in the United States. Gastro-
26. Klein S, Wadden T, Sugerman HJ. AGA                  troenterol Clin North Am. 2010;39(2):369–             enterology. 1989;96(2 Pt 1):487–492
    technical review on obesity. Gastroenterol-          379, x                                            49. Everhart JE, Khare M, Hill M, Maurer KR.
    ogy. 2002;123(3):882–932                         38. Bennion LJ, Ginsberg RL, Gernick MB, Bennett          Prevalence and ethnic differences in gall-
27. Dittrick GW, Thompson JS, Campos D,                  PH. Effects of oral contraceptives on the             bladder disease in the United States. Gas-
    Bremers D, Sudan D. Gallbladder pathology            gallbladder bile of normal women. N Engl              troenterology. 1999;117(3):632–639
    in morbid obesity. Obes Surg. 2005;15(2):            J Med. 1976;294(4):189–192                        50. Méndez-Sánchez N, King-Martínez AC,
    238–242                                          39. Cirillo DJ, Wallace RB, Rodabough RJ, et al.          Ramos MH, Pichardo-Bahena R, Uribe M.
28. Shaffer EA. Gallstone disease: epidemiol-            Effect of estrogen therapy on gallbladder             The Amerindian’s genes in the Mexican
    ogy of gallbladder stone disease. Best               disease. JAMA. 2005;293(3):330–339                    population are associated with development
    Pract Res Clin Gastroenterol. 2006;20(6):        40. Valdivieso V, Covarrubias C, Siegel F, Cruz F.        of gallstone disease. Am J Gastroenterol.
    981–996                                              Pregnancy and cholelithiasis: pathogenesis            2004;99(11):2166–2170
29. Centers for Disease Control and Pre-                 and natural course of gallstones diagnosed in     51. Diehl AK, Stern MP. Special health problems
    vention. Growth charts. Available at: www.           early puerperium. Hepatology. 1993;17(1):1–4          of Mexican-Americans: obesity, gallbladder
    cdc.gov/growthcharts/. Accessed February         41. Ko CW, Beresford SAA, Schulte SJ, Matsumoto           disease, diabetes mellitus, and cardiovascu-
    22, 2011                                             AM, Lee SP. Incidence, natural history, and           lar disease. Adv Intern Med. 1989;34:73–96
30. Suell MN, Horton TM, Dishop MK, Mahoney              risk factors for biliary sludge and stones        52. Puppala S, Dodd GD, Fowler S, et al. A
    DH, Olutoye OO, Mueller BU. Outcomes for             during pregnancy. Hepatology. 2005;41(2):             genomewide search finds major suscepti-
    children with gallbladder abnormalities              359–365                                               bility loci for gallbladder disease on chro-
    and sickle cell disease. J Pediatr. 2004;145     42. Thijs C, Knipschild P. Oral contraceptives            mosome 1 in Mexican Americans. Am J
    (5):617–621                                          and the risk of gallbladder disease: a meta-          Hum Genet. 2006;78(3):377–392
31. Rennels MB, Dunne MG, Grossman NJ,                   analysis. Am J Public Health. 1993;83(8):         53. Katsika D, Grjibovski A, Einarsson C, Lammert
    Schwartz AD. Cholelithiasis in patients with         1113–1120                                             F, Lichtenstein P, Marschall HU. Genetic and
    major sickle hemoglobinopathies. Am J Dis        43. Wang HH, Liu M, Clegg DJ, Portincasa P,               environmental influences on symptomatic
    Child. 1984;138(1):66–67                             Wang DQ. New insights into the molecular              gallstone disease: a Swedish study of
32. Karayalcin G, Hassani N, Abrams M,                   mechanisms underlying effects of estrogen             43,141 twin pairs. Hepatology. 2005;41(5):
    Lanzkowsky P. Cholelithiasis in children with        on cholesterol gallstone formation. Biochim           1138–1143
    sickle cell disease. Am J Dis Child. 1979;133        Biophys Acta. 2009;1791(11):1037–1047             54. City of Houston Planning and Development
    (3):306–307                                      44. Kern F, Jr,Everson GT, DeMark B, et al. Biliary       Department. Demographic data. Available at:
33. Al-Salem AH, Qaisaruddin S, Al-Dabbous I,            lipids, bile acids, and gallbladder function in       www.houstontx.gov/planning/Demographics/
    et al. Cholelithiasis in children with sickle        the human female. Effects of pregnancy and            demog_links.html. Accessed February 22,
    cell disease. Pediatr Surg Int. 1996;11(7):          the ovulatory cycle. J Clin Invest. 1981;68(5):       2011
    471–473                                              1229–1242                                         55. Haricharan RN, Proklova LV, Aprahamian CJ,
34. Ozden N, DiBaise JK. Gallbladder ejection        45. Von Bergmann K, Becker M, Leiss O. Biliary            et al. Laparoscopic cholecystectomy for
    fraction and symptom outcome in patients             cholesterol saturation in non-obese women             biliary dyskinesia in children provides du-
    with acalculous biliary-like pain. Dig Dis           and non-obese men before and after pu-                rable symptom relief. J Pediatr Surg. 2008;
    Sci. 2003;48(5):890–897                              berty. Eur J Clin Invest. 1986;16(6):531–535          43(6):1060–1064
35. Vegunta RK, Raso M, Pollock J, et al. Biliary    46. Bennion LJ, Knowler WC, Mott DM, Spagnola         56. Scott Nelson R, Kolts R, Park R, Heikenen J.
    dyskinesia: the most common indication               AM, Bennett PH. Development of lithogenic             A comparison of cholecystectomy and ob-
    for cholecystectomy in children. Surgery.            bile during puberty in Pima indians. N Engl           servation in children with biliary dyskine-
    2005;138(4):726–731, discussion 731–733              J Med. 1979;300(16):873–876                           sia. J Pediatr Surg. 2006;41(11):1894–1898

PEDIATRICS Volume 129, Number 1, January 2012                                                                                                             7
                                                Downloaded from by guest on November 4, 2015
Clinical Characteristics and Risk Factors for Symptomatic Pediatric Gallbladder
                                      Disease
 Seema Mehta, Monica E. Lopez, Bruno P. Chumpitazi, Mark V. Mazziotti, Mary L.
                          Brandt and Douglas S. Fishman
            Pediatrics; originally published online December 12, 2011;
                           DOI: 10.1542/peds.2011-0579
 Updated Information &              including high resolution figures, can be found at:
 Services                           /content/early/2011/12/07/peds.2011-0579
 Citations                          This article has been cited by 5 HighWire-hosted articles:
                                    /content/early/2011/12/07/peds.2011-0579#related-urls
 Permissions & Licensing            Information about reproducing this article in parts (figures,
                                    tables) or in its entirety can be found online at:
                                    /site/misc/Permissions.xhtml
 Reprints                           Information about ordering reprints can be found online:
                                    /site/misc/reprints.xhtml

 PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
 publication, it has been published continuously since 1948. PEDIATRICS is owned, published,
 and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk
 Grove Village, Illinois, 60007. Copyright © 2011 by the American Academy of Pediatrics. All
 rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.

                           Downloaded from by guest on November 4, 2015
Clinical Characteristics and Risk Factors for Symptomatic Pediatric Gallbladder
                                      Disease
 Seema Mehta, Monica E. Lopez, Bruno P. Chumpitazi, Mark V. Mazziotti, Mary L.
                          Brandt and Douglas S. Fishman
            Pediatrics; originally published online December 12, 2011;
                           DOI: 10.1542/peds.2011-0579

  The online version of this article, along with updated information and services, is
                         located on the World Wide Web at:
                        /content/early/2011/12/07/peds.2011-0579

   PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
   publication, it has been published continuously since 1948. PEDIATRICS is owned,
   published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
   Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2011 by the American Academy
   of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.

                          Downloaded from by guest on November 4, 2015
You can also read